International Business Machines Corp. (NYSE:IBM), Bausch + Lomb to create iPhone app for cataract surgeons

Share on FacebookTweet about this on TwitterShare on Google+Share on RedditShare on LinkedInPrint this pageEmail this to someone

International Business Machines Corp. (NYSE:IBM) is collaborating with Bausch + Lomb, a wholly-owned subsidiary of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), to create an app targeting cataract surgeons. The collaboration builds upon the deal IBM inked with Apple Inc. (NASDAQ:AAPL) in 2014 to create enterprise-grade apps for iOS devices.

International Business Machines Corp. (NYSE:IBM) and Bausch + Lomb will be bringing to the table their unique expertise in creating the iOS app for eye surgeons. Bausch + Lomb boasts about 163 years in the business of supplying eye health products that include items such as contact lenses. The deal with IBM is expected to help Bausch + Lomb renew itself so that it can continue supplying innovative products to its customers.

As for International Business Machines Corp. (NYSE:IBM), the collaboration with Bausch + Lomb gives it another opportunity to double down on healthcare-themed technology. IBM engineers will be working with cataract specialists at Bausch + Lomb to create an app that runs perfectly on iOS environment.

Streamlining operating room workflow

The idea of the app will be to help streamline workflow for doctors operating on cataract patients. With the app IBM and Bausch + Lomb want to bring transformative changes to how cataracts surgeries are performed starting from planning stage to post surgery follow up.

Using the app, surgeons will be able to easily compile patient information. The app will also assist cataract surgeons in the selection of intraocular lens (IOL). IBM and Bausch + Lomb also say the app will help modernize the operating room in the sense that doctors will be able to refer to their iPhone for notes instead of paper notes they usually carry to the theatre.

When will the work begin?

International Business Machines Corp. (NYSE:IBM) and Bausch + Lomb want to hit the ground running. As such, later this year they will be doing a pilot study test for the app. Patient data collected using the app will be store in IBM’s secure cloud environment.

Apple in enterprise

With growth opportunities running out in the consumer electronics market, Apple is teaming up with enterprise facing technology companies to help it break into the business market. As such, Apple teamed up with International Business Machines Corp. (NYSE:IBM) in 2014 to develop native iOS tools and solutions for the enterprise market and the latest cataract app project adds to the collaboration.

Neha Gupta

Neha Gupta has been in the financial space for over six years now. Gupta earned her MBA degree from Symbiosis Centre of Distance Learning in 2009 and her passion for finance led her to pursue Chartered Financial Analyst (CFA) course. She has successfully completed Level II of her CFA. She is a veteran in article writing, which is depicted in her numerous pieces published on SeekingAlpha, Nextiphonenews, InsiderMonkey, MarketWatch, and Techinsider. Her crisp and eloquent writing finds its best place in Researchcows, where emphasis is given on developing rich content for various websites, products, business plans, trainings, and book writing.

You may also like...

Read previous post:
Microsoft Corporation (NASDAQ:MSFT) logo
How Microsoft Corporation (NASDAQ:MSFT) is giving Apple (AAPL) a run for its money in the tablet market

It has emerged that Microsoft Corporation (NASDAQ:MSFT)’s 2-in-1 Surface devices and Apple Inc. (NASDAQ:AAPL)’s iPads are locked in a dead...

Close